Search results for: 'double drug bu'

10 Aug 2020  |  South Asia, Middle East & North Africa  |  Market Research

Transformative Trends and Innovative Business Models Powering the Indian Electric Bus Market

Future Growth Potential Enhanced by New Business Models and Low Cost of Ownership Opportunity in the Electric Bus Market

Infographics

×

This study on the Indian electric bus (eBus) market discusses the key influencing trends that are driving the growth in this segment. Government Initiatives in India to promote electric buses, state government initiatives, and FAME-II overview and incentives schemes are discussed in this study. The tenders in different cities for procuring the elec...

Frost & Sullivan’s mobility team tracks the global commercial vehicle (CV) market to generate deep-dive analysis on the shift towards zero-emission buses and the implications of new technologies on the passenger transportation landscape of the future. The commercial mobility practice evaluates applications in the global transit and coach buses spac...

Diabetes has exhibited dramatic increases during the past decade, registering a global prevalence of 9% among adults aged 18 years and older, and is projected to be the 7th-leading cause of death by 2030. The most popular treatment for type 1 diabetes mellitus (T1DM) is multiple daily insulin (MDI) injections. However, researchers globally are work...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) encompasses insights across advances in targeted neurological therapies, cancer treatments, and AI-powered drug development. The TOE also features innovators for treatment of metabolic diseases such as obesity and heart failure.The Life Science, Health & Wellnes...

12 Aug 2020  |  North America  |  Market Research

New Drug Development for Rare Pediatric Disorders Sustaining High Growth in the Global Orphan Drugs Market, 2019–2025

AI-powered Early Disease Diagnosis and Drug Repurposing will Create New Growth Opportunities

Infographics

×

Key Issues Addressed

Rare diseases have been an increasing area of focus as three waves have converged in recent years: genomic research and innovations becoming mainstream; the forthcoming regulatory policies and financial incentives put in place by the federal agencies; and the increasingly patient-centric and coordinated efforts of patient advocacy groups, caregive...

For many IT departments, the drive to deliver new services faster than ever before has led them to seek faster and more efficient means of supporting complex, business-critical applications like Enterprise Resource Planning (ERP) applications—particularly those deployed using market-leading Oracle and SAP platforms. Managed application services hav...

Excipients are used to support the delivery of the APIs (active pharmaceutical ingredients) through oral dosage, parenteral, and transdermal medications. For oral dosages, the key delivery forms are tablets and capsules. This research service covers the North American oral solid drug dosage excipients market. Based on functionality, excipients are ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent technology advances across cell & gene therapies, immunotherapies, intelligent drug discovery approaches, automated biomanufacturing and microbiome sciences. The TOE also encompasses recent developments in proteomics, drug deliver...

This Frost Radar™ analyzes the competitive landscape of the antibody-drug conjugate (ADC) contract development and manufacturing organization (CDMO) market. Companies provide the foundational manufacturing and development services for what has become one of the most dynamic and valuable therapeutic modalities in oncology. The success of the ADC rev...